Hamamatsu Pharma Research, Inc. is dedicated to preclinical efficacy evaluation of novel therapeutics in non-human primate disease models, including pain (chemotherapy-induced neuropathic pain & osteoarthritis) and cerebral ischemia/stroke.
Contact
Aldric Hama, Phd.
Director, Overseas Contract Studies
Email: [email protected]
Phone: +81 53-543-4543
www.hpharmausa.com
400 N Tustin Ave Ste 240
Santa Ana,
CA
92705